|Last Price$46.50||Day Change (%)-0.23%|
|Open Price$46.46||Day Change ($)-0.10|
|Day Range46.16–46.77||52-Week Range33.12–48.63|
As of Mon 9/26/2016 2:19:00 PM | USD
Agilent Technologies Prices $300 Million of Senior Notes
Global Magnetic Resonance Imaging (MRI) Market Research and Analysis 2014-2020 - Key Players are GE Healthcare, Hologic, Emergence Teleradiology, Planmed, Aurora Imaging, Fonar & Agilent Technologies - Research and Markets
Genome Editing Global Market to Grow 31.1% by 2022 - Increased R&D Expenditure in Biotechnology & Pharmaceutical Industries - Research and Markets
CBRNE (Chemical, Biological, Radiological, Nuclear And Explosive) Detection Device Markets: Market Strategies and Forecasts, Worldwide, 2016-2022 - Research and Markets
IR Spectroscopy Market Worth USD 1.26 Billion by 2022 - Advancements in Biotechnology & Pharmaceuticals Industries in U.S. - Research and Markets
You'll be surprised at which funds are poised for a large-growth rebound.
Agilent A reported full-year results indicating respectable revenue growth and continued improvements to profitability. We've updated our model to reflect fiscal 2006 results and are maintaining our fair value estimate. Revenues in the bio-analytical division grew 9% over last year, matching our ...
Agilent's A third-quarter gross margin was well ahead of our expectations for the quarter, and the company produced another respectable performance in year-over-year sales (15%) and order (11%) growth. The gross margin finished at 55%, much higher than our assumption for the quarter and 5 ...
This report includes candid statements and observations regarding investment strategies, individual securities, and economic and market conditions; however, there is no guarantee that these statements, opinions or forecasts will prove to be correct. Equity markets are volatile and an investor may ...
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...